Marvel Biosciences Corp

NEW
TSXV:MRVL (Canada)  
C$ 0.16 -0.0050 (-3.03%) Jul 8
At Loss
Market Cap:
C$ 10.09M ($ 7.11M)
Enterprise V:
C$ 11.05M ($ 7.79M)
Volume:
180.01K
Avg Vol (2M):
81.39K
Trade In:
Volume:
180.01K
At Loss

Business Description

Description
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
Name Current Vs Industry Vs History
Cash-To-Debt
0.31
Equity-to-Asset
-5.79
Debt-to-Equity
-0.51
Debt-to-EBITDA
-1.3
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
19.3
3-Year EPS without NRI Growth Rate
15.7
3-Year FCF Growth Rate
29
Name Current Vs Industry Vs History
5-Day RSI
45.08
9-Day RSI
44.95
14-Day RSI
46.49
3-1 Month Momentum %
17.65
6-1 Month Momentum %
42.86
12-1 Month Momentum %
21.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.18
Quick Ratio
0.18
Cash Ratio
0.17
Days Payable
1407.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-12.6
Shareholder Yield %
-3.8
Name Current Vs Industry Vs History
ROA %
-302
ROIC %
-43.9
Moat Score
3
Tariff Resilience Score
5

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-10.26
EV-to-EBITDA
-10.26
EV-to-FCF
-13.79
Earnings Yield (Greenblatt) %
-9.74
FCF Yield %
-7.71

Financials

TSXV:MRVL's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Marvel Biosciences Corp Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -0.04
Beta 0.6196
3-Year Sharpe Ratio 0.53
3-Year Sortino Ratio 1.04
Volatility % 86.06
14-Day RSI 46.49
14-Day ATR (C$) 0.020371
20-Day SMA (C$) 0.175
12-1 Month Momentum % 21.21
52-Week Range (C$) 0.115 - 0.4
Shares Outstanding (Mil) 63.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Marvel Biosciences Corp Filings

Filing Date Document Date Form
No Filing Data

Marvel Biosciences Corp Stock Events

Financials Calendars
Event Date Price (C$)
No Event Data

Marvel Biosciences Corp Frequently Asked Questions

What is Marvel Biosciences Corp(TSXV:MRVL)'s stock price today?
The current price of TSXV:MRVL is C$0.16. The 52 week high of TSXV:MRVL is C$0.40 and 52 week low is C$0.12.
When is next earnings date of Marvel Biosciences Corp(TSXV:MRVL)?
The next earnings date of Marvel Biosciences Corp(TSXV:MRVL) is .
Does Marvel Biosciences Corp(TSXV:MRVL) pay dividends? If so, how much?
Marvel Biosciences Corp(TSXV:MRVL) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Marvel Biosciences Corp

No articles.